EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advances in the pathogenesis and clinical management of pulmonary hypertension

Yi Yan iD, Zhuoyuan Xu, Yanghanyue Zhou, Xike Wang, Hao Zhang

Medical Review · 24.04.2026 · 6 (2) · 120-141

DOI: 10.1515/mr-2026-0002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Review, online erschienen am 20.03.2026. Verfasst von Yi Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center and Shanghai Institute of Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, National Children's Medical Center, Sh…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Project of National Clinical Key Specialty Construction Project, the Project of National Natural Science Foundation of China, Shanghai Key Research Center Construction Project-Shanghai Research Center for Pediatric Cardiovascular Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH) is a severe cardiopulmonary disorder characterized by pulmonary vascular remodeling, which leads to increased pulmonary vascular resistance (PVR), right ventricular (RV) hypertrophy, and ultimately heart failure and death. This review explores the dual landscape of PH, integrating recent insights into its complex pathogenesis with evolving clinical management strategies. The pathogenesis of PH involves a complex interplay of genetics, metabolism, immune dysfunction, biomechanical force and other factors, all contributing to vascular remodeling and presenting opportunities for novel therapies and biomarkers. Among these, certain pathogenic mechanisms are of particular relevance and may hold distinct importance in the pediatric population. Concurrently, notable progress has been made in clinical front including diagnosis, risk stratification, drug development, interventional or surgical procedures, and imaging technologies. Hence, this review integrates current evidence in both PH pathogenesis and clinical management to guide future research toward novel therapies and precision medicine.

Schlagwörter

Stichwörter der Autor:innen

clinical managementpathogenesispulmonary hypertension

Autor:innen und Institutionen

  • Heart Center and Shanghai Institute of Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, National Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Clinical Research Center for Rare Pediatric Diseases, Shanghai Children's Medical Center, National Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Guizhou Branch of Shanghai Children's Medical Center, Guizhou Provincial People's Hospital, Guizhou Province, China.

ORCID-Profile: Yi Yan

Förderung

  • the Project of National Clinical Key Specialty Construction Project
  • the Project of National Natural Science Foundation of China
  • Shanghai Key Research Center Construction Project-Shanghai Research Center for Pediatric Cardiovascular Diseases
  • the Project of Shanghai Municipal Science and Technology Commission
  • Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics
  • Innovative Research Team of High-level Local University in Shanghai
  • Shanghai Eastern Talent Plan
  • Shanghai Magnolia Talent Plan Pujiang Project

Zitieren

APA

Yan, Y., Xu, Z., Zhou, Y., Wang, X., & Zhang, H. (2026). Advances in the pathogenesis and clinical management of pulmonary hypertension. Medical Review, 6(2), 120-141. https://doi.org/10.1515/mr-2026-0002

Vancouver

Yan Y, Xu Z, Zhou Y, Wang X, Zhang H. Advances in the pathogenesis and clinical management of pulmonary hypertension. Medical Review. 2026;6(2):120-141. doi:10.1515/mr-2026-0002

BibTeX
@article{Yan2026,
  author = {Yan, Yi and Xu, Zhuoyuan and Zhou, Yanghanyue and Wang, Xike and Zhang, Hao},
  title = {Advances in the pathogenesis and clinical management of pulmonary hypertension},
  journal = {Medical Review},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {120--141},
  doi = {10.1515/mr-2026-0002}
}
Kostenlos starten →